Moody Aldrich Partners’s Deciphera Pharmaceuticals, Inc. Common Stock DCPH Stock Holding History

Moody Aldrich Partners’s Portfolio DCPH Stock Details DCPH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q2	–	Sell	-63,423	Closed	-$2.84M	–	202
2021 Q1	$2.84M	Buy	63,423 +1,358	+2%	+$63.2K	0.41%	82
2020 Q4	$3.54M	Buy	62,065 +56	+0.1%	+$3.32K	0.57%	80
2020 Q3	$3.18M	Buy	62,009 +841	+1%	+$41.2K	0.67%	70
2020 Q2	$3.65M	Buy	61,168 +8,599	+16%	+$460K	0.78%	55
2020 Q1	$2.16M	Buy	52,569 +52	+0.1%	+$2.89K	0.65%	65
2019 Q4	$3.27M	Buy	52,517 +1,066	+2%	+$50.7K	0.67%	62
2019 Q3	$1.75M	Buy	+51,451	New	+$1.52M	0.46%	79

Other funds holding DCPH

Redmile Group San Francisco, California $1.51B AUM 164.17% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return

Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

ACH

ArrowMark Colorado Holdings Denver, Colorado $3.76B AUM 21.77% 1-Year Est. Return

Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return

LGM

Logos Global Management San Francisco, California $2B AUM 444.09% 1-Year Est. Return

ACA

Avoro Capital Advisors New York $10.2B AUM 149.19% 1-Year Est. Return

Moody Aldrich Partners's DCPH Position: Q2 2021 in Review

Moody Aldrich Partners sold out of Deciphera Pharmaceuticals, Inc. Common Stock (DCPH) in Q2 2021, closing a stake of 63,423 shares — an estimated $2.84M sold.

Moody Aldrich Partners first reported a position in DCPH in Q3 2019 and held it in 7 quarters. The position peaked at $3.65M in Q2 2020. 147 funds tracked by Wall St. Rank hold DCPH as of Q2 2021.

Moody Aldrich Partners reported no remaining Deciphera Pharmaceuticals, Inc. Common Stock position as of Q2 2021 after selling out during the quarter.
Moody Aldrich Partners sold 63,423 Deciphera Pharmaceuticals, Inc. Common Stock shares in Q2 2021, an estimated $2.84M.
Moody Aldrich Partners first reported a position in Deciphera Pharmaceuticals, Inc. Common Stock in Q3 2019 and held it in 7 quarters.
Moody Aldrich Partners's Deciphera Pharmaceuticals, Inc. Common Stock position peaked at $3.65M in Q2 2020.
147 funds tracked by Wall St. Rank held Deciphera Pharmaceuticals, Inc. Common Stock as of Q2 2021.

Based on Moody Aldrich Partners's 13F filing for Q2 2021, filed 4 Aug 2021.